article thumbnail

The B2C prescription: Marketing lessons for B2B pharma companies

pharmaphorum

Learn valuable marketing lessons for B2B pharma companies by examining successful strategies used in the B2C prescription market, including over-the-counter (OTC) products and interactions with healthcare professionals (HCPs).

article thumbnail

Benefits of PCD Pharma Company

Fossil Remedies

In the pharma sector, running a PCD Pharma Company in India guarantees good returns. What is a PCD Pharma Company? In this model, PCD pharma companies are those who give products to the established companies and give monopoly rights to a region. Are you a small entrepreneur in the niche?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Product launch metrics are changing in pharma

World of DTC Marketing

The old model of looking at performance in the first six months of product launch isn’t relevant. Today, colossal budget product launches are not returning the same ROI as before. Product launches are going to need to be micro-targeted to specific audiences. What is the definition of a successful pharma product launch?

article thumbnail

Eczac?ba?? to acquire Turkish pharma company Gensenta for $135m

Pharmaceutical Technology

will move a step closer to becoming a key healthcare player in Turkey and global markets. Amgen Turkey noted that the company will maintain its operations and serve its patients in the region. to acquire Turkish pharma company Gensenta for $135m appeared first on Pharmaceutical Technology. The post Eczac?ba??

article thumbnail

Laurus Labs and IIT Kanpur partner for new gene therapy products

Pharmaceutical Technology

Indian pharmaceutical company Laurus Labs has signed a memorandum of agreement (MoA) with the Indian Institute of Technology, Kanpur (IIT Kanpur) to bring new gene therapy products to the market. Laurus Labs will be responsible for launching these products in India and emerging markets.

article thumbnail

The biggest transformation in pharma marketing since DTC

World of DTC Marketing

This is an exciting time to be in healthcare marketing. We’re witnessing the most significant transformation in healthcare marketing since DTC was approved in the ’90s. is no more an option but the critical factor to ensure success for any multichannel marketing initiatives.

Marketing 202
article thumbnail

Boehringer Ingelheim Aims to Bring 25 New Products to Market by 2030

BioSpace

The German bio pharma company on Tuesday announced ambitious pipeline plans that include starting 10 new Phase II and III trials over the next 12 to 18 months.